A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

NCT01647516 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

NCT05953402 ·Status: NOT_YET_RECRUITING

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769 ·Status: COMPLETED ·Phase: PHASE3

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

NCT06073873 ·Status: RECRUITING

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

NCT06311123 ·Status: RECRUITING

Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

NCT05809583 ·Status: WITHDRAWN

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

NCT03464097 ·Status: TERMINATED ·Phase: PHASE3

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440372 ·Status: TERMINATED ·Phase: PHASE3

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

NCT06126835 ·Status: ACTIVE_NOT_RECRUITING

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

NCT04209556 ·Status: WITHDRAWN ·Phase: PHASE2

Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

NCT05702879 ·Status: RECRUITING

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

NCT04882007 ·Status: COMPLETED ·Phase: PHASE2

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

NCT00307827 ·Status: TERMINATED ·Phase: PHASE2

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

NCT02958865 ·Status: COMPLETED ·Phase: PHASE2

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

NCT00209300 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis

NCT01453491 ·Status: COMPLETED ·Phase: PHASE1

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

NCT03467958 ·Status: TERMINATED ·Phase: PHASE3

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06290934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

NCT02895100 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

NCT00659802 ·Status: COMPLETED ·Phase: PHASE2